Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Naturalistic Study of the Efficacy and Safety of Escitalopram in Treatment Resistant Depression

NCT00220480 is registered in ClinicalTrials.gov with Sheba Medical Center as lead sponsor.

NCT NCT00220480
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00220480 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Naturalistic Study of the Efficacy and Safety of Escitalopram in Treatment Resistant Depression
Lead sponsor
Sheba Medical Center
Phase
Not applicable
Overall status
Unknown status
Start date
February 28, 2005
Completion date
Not reported
Enrollment
60 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

depressive disorder, major